COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge

Willa Cochran; Pali Shah; Lindsay Barker; Julie Langlee; Kristin Freed; Lauren Boyer; R. Scott Anderson; Maura Belden; Jaclyn Bannon; Olivia S. Kates; Nitipong Permpalung; Heba Mostafa; Dorry L. Segev; Daniel C. Brennan; Robin K. Avery

doi:10.1097/TP.0000000000004162

COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge

Willa Cochran, Pali Shah, Lindsay Barker, Julie Langlee, Kristin Freed, Lauren Boyer, R. Scott Anderson, Maura Belden, Jaclyn Bannon, Olivia S. Kates, Nitipong Permpalung, Heba Mostafa, Dorry L. Segev, Daniel C. Brennan, Robin K. Avery

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	E346-E347
Journal	Transplantation
Volume	106
Issue number	7
DOIs	https://doi.org/10.1097/TP.0000000000004162
State	Published - Jul 1 2022

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/TP.0000000000004162

Cite this

Cochran, W., Shah, P., Barker, L., Langlee, J., Freed, K., Boyer, L., Scott Anderson, R., Belden, M., Bannon, J., Kates, O. S., Permpalung, N., Mostafa, H., Segev, D. L., Brennan, D. C., & Avery, R. K. (2022). COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge. Transplantation, 106(7), E346-E347. https://doi.org/10.1097/TP.0000000000004162

@article{60bc6292e48648f8941c6b47cf0f3604,

title = "COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge",

author = "Willa Cochran and Pali Shah and Lindsay Barker and Julie Langlee and Kristin Freed and Lauren Boyer and {Scott Anderson}, R. and Maura Belden and Jaclyn Bannon and Kates, {Olivia S.} and Nitipong Permpalung and Heba Mostafa and Segev, {Dorry L.} and Brennan, {Daniel C.} and Avery, {Robin K.}",

note = "Funding Information: W.C. has received a consulting fee from DKB Med. N.P. has received grant support from CareDx outside the submitted work and has served on the Advisory Board for Shionogi Inc and the Data Review Committee for Pulmocide Ltd. D.C.B. has received consulting/speaking honoraria from Allovir, Amplyx, Argenyx, CareDx, Natera, Sanofi, and Veloxis. D.L.S. has received consulting/speaking honoraria from Sanofi, Novartis, CSL Behring, and Veloxis. R.K.A. has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK. Funding Information: W.C. has received a consulting fee from DKB Med. N.P. has received grant support from CareDx outside the submitted work and has served on the Advisory Board for Shionogi Inc and the Data Review Committee for Pulmocide Ltd. D.C.B. has received consulting/speaking honoraria from Allovir, Amplyx, Argenyx, CareDx, Natera, Sanofi, and Veloxis. D.L.S. has received consulting/speaking honoraria from Sanofi, Novartis, CSL Behring, and Veloxis. R.K.A. has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK. ",

year = "2022",

month = jul,

day = "1",

doi = "10.1097/TP.0000000000004162",

language = "English (US)",

volume = "106",

pages = "E346--E347",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge

AU - Cochran, Willa

AU - Shah, Pali

AU - Barker, Lindsay

AU - Langlee, Julie

AU - Freed, Kristin

AU - Boyer, Lauren

AU - Scott Anderson, R.

AU - Belden, Maura

AU - Bannon, Jaclyn

AU - Kates, Olivia S.

AU - Permpalung, Nitipong

AU - Mostafa, Heba

AU - Segev, Dorry L.

AU - Brennan, Daniel C.

AU - Avery, Robin K.

N1 - Funding Information: W.C. has received a consulting fee from DKB Med. N.P. has received grant support from CareDx outside the submitted work and has served on the Advisory Board for Shionogi Inc and the Data Review Committee for Pulmocide Ltd. D.C.B. has received consulting/speaking honoraria from Allovir, Amplyx, Argenyx, CareDx, Natera, Sanofi, and Veloxis. D.L.S. has received consulting/speaking honoraria from Sanofi, Novartis, CSL Behring, and Veloxis. R.K.A. has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK. Funding Information: W.C. has received a consulting fee from DKB Med. N.P. has received grant support from CareDx outside the submitted work and has served on the Advisory Board for Shionogi Inc and the Data Review Committee for Pulmocide Ltd. D.C.B. has received consulting/speaking honoraria from Allovir, Amplyx, Argenyx, CareDx, Natera, Sanofi, and Veloxis. D.L.S. has received consulting/speaking honoraria from Sanofi, Novartis, CSL Behring, and Veloxis. R.K.A. has received study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK.

PY - 2022/7/1

Y1 - 2022/7/1

UR - http://www.scopus.com/inward/record.url?scp=85131059478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131059478&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000004162

DO - 10.1097/TP.0000000000004162

M3 - Letter

C2 - 35404880

AN - SCOPUS:85131059478

SN - 0041-1337

VL - 106

SP - E346-E347

JO - Transplantation

JF - Transplantation

IS - 7

ER -

COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this